If you formerly lived in Sudan or South Sudan between November 4, 1997 and December 31, 2011 and have refugee or asylum status in the United States, a class action lawsuit may affect your rights
NEW YORK, Feb. 4, 2025 /PRNewswire/ -- What is this class action lawsuit about? The French bank BNP Paribas, S.A. ('BNPP SA') and its U.S. affiliate ('BNPP US') (together the 'Defendants') are accused of knowingly funding the Government of Sudan's human rights abuses between November 1997 and December 2011. Defendants deny these allegations. The lawsuit is Kashef v BNP Paribas SA, 16 Civ. 3228(AKH) in federal court in the Southern District of New York.
Who is a member of the class action lawsuit? If you were granted refugee or asylum status by the U.S. government, and formerly lived in Sudan or South Sudan between November 4, 1997 and December 31, 2011, you are a member of the Class and may be able to seek money compensation for your injuries.
What happens next? Those who wish to be eligible to seek individual damages will have to so indicate by opting in. Promptly after they do so, they will receive a questionnaire, by which they can advise the lawyers and the Court of the necessary details about their claims. One or more trials, or a settlement, may follow.
Do I need to get a lawyer? No. The Court appointed Kathryn Lee Boyd, of Hecht Partners LLP, and Michael Hausfeld, of Hausfeld LLP, to represent Class Members (the 'Class Counsel') at the trial. You do not need to get your own attorney, but you may do so if you wish.
How can I seek money compensation for my injuries as part of the class action?
You MUST complete an opt-in form and a questionnaire online by midnight ET on July 1, 2025. Personally identifiable information you provide will be protected and kept confidential by order of the Court, and will be available only to the Special Master, the Court, and internal and external legal counsel for the parties in this lawsuit.
Even if you have provided information to Class Counsel in the past, you MUST complete the opt-in form and the questionnaire, to be sent to the Special Master.
Instructions for accessing and completing the opt-in form and the questionnaire are available at www.kashefvbnpp.com (Sudanese Arabic available).
***
If you are a member of the Class, the following legal rights and options are available to you:
SEEK MONEY COMPENSATION FOR YOUR INJURIES. You must take action to seek money compensation for your injuries and losses. If between November 4, 1997 and December 31, 2011 you suffered injuries or lost property by the Government of Sudan's military, security services, police, or militias, including the Janjaweed, then you may be able to seek money compensation if you complete the opt-in form and the questionnaire. The opt-in form and the questionnaire are available at: www.kashefvbnpp.com (Sudanese Arabic available). You must do this by midnight ET on July 1, 2025.
OR
ASK TO BE EXCLUDED FROM THE CLASS ACTION. If you ask to be excluded from the Class Action, you will be excluded from the lawsuit, and you will not receive any money, if money is awarded to Class Members. To bring your own case against the Defendants, you must find a new attorney, or proceed without an attorney. If you want to file your own suit, please be aware that there is a statute of limitations that is as short as two days after you submit your opt-out notice; consult your lawyer quickly. To ask to be excluded from this class action, you must complete an opt-out form that is available on the website www.kashefvbnpp.com by midnight ET on July 1, 2025.
OR
DO NOTHING. If you do not ask to be excluded, you are included in the lawsuit and accept the outcome of the trial. IMPORTANT: you must complete the opt-in form and answer the questionnaire to seek any money compensation for your injuries. If you do not complete the opt-in form and the questionnaire, you will NOT be able to seek any money compensation for your injuries.
***
If you have any questions, find more information online at: www.kashefvbnpp.com (Sudanese Arabic available) or Call Class Counsel Kathryn Lee Boyd at +1 (332) 334-7771 or Michael Hausfeld at +1 (771) 333-6786 (Sudanese interpreters available).
View original content: https://www.prnewswire.com/news-releases/if-you-formerly-lived-in-sudan-or-south-sudan-between-november-4-1997-and-december-31-2011-and-have-refugee-or-asylum-status-in-the-united-states-a-class-action-lawsuit-may-affect-your-rights-302368075.html
SOURCE United States District Court for the Southern District of New York
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
28 minutes ago
- Yahoo
BlackRock Launches New Synthetic S 500 ETF in France
BlackRock is expanding its Plan d'Epargne en Actions (PEA) compliant exchange-traded fund range targeting French investors with the launch of a synthetic S&P 500 ETF. The iShares S&P 500 Swap PEA UCITS ETF (SPEA) is listed on Euronext Paris with a total expense ratio of 0.1%. SPEA tracks the S&P 500 Net TR Index in EUR index, which is a Euro-denominated version of the index tracked by the iShares S&P 500 Swap UCITS ETF (I500). SPEA is eligible for the PEA, a French tax-advantaged investment account available to French residents. It offers tax benefits on capital gains and dividends if the investments are held for at least five years. Normally, PEAs only allow investment in European Union-domiciled equities, so funds tracking non-European indices use swap-based replication to maintain PEA compliance. Like I500, SPEA captures the top 500 stocks from U.S. companies in leading industries of the U.S. economy. SPEA does not pay withholding tax on dividends, as the substitute basket of the ETF is restricted to non-dividend-paying stocks. SPEA continues the U-turn carried out by the world's largest manager and its previous stance against synthetic ETFs after it launched a swap-based MSCI world ETF that was PEA-eligible in April last year. The iShares MSCI World Swap PEA UCITS ETF (WPEA) is listed on the Euronext Paris with a total expense ratio of 0.25%. The ETF tracks the MSCI World Net TR Eur index, a euro-denominated version of the index tracked by the iShares MSCI World Swap UCITS ETF (IWDS), which launched in March. WPEA offers exposure to 1,480 equities across 23 developed market countries. It operates an unfunded swap model where a counterparty pays the index total return in exchange for a swap fee. This article was originally published at sister publication ETF | © Copyright 2025 All rights reserved Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
43 minutes ago
- Yahoo
New IBO Survey Reveals Major Cuts to Lab Budgets Amid NIH Grant Terminations
ARLINGTON, Va., June 10, 2025 /PRNewswire/ -- A new survey conducted by Instrument Business Outlook (IBO) has uncovered significant reductions in laboratory budgets across the U.S. academic and government research landscape, with lab product spending sharply impacted by recent NIH grant terminations. The findings, based on an exclusive IBO survey, shed light on the growing financial uncertainty facing scientific research labs in 2025. The results follow widespread disruptions in NIH funding, with more than 1,500 grants totaling $7.5 billion terminated as of May 20, according to data from Grant Watch. While the exact numbers remain fluid due to inconsistent reporting by federal agencies, the toll is undeniable: R01 research grants—a cornerstone of basic research—have been particularly hard-hit, with 322 grants worth nearly $790 million terminated. "The fallout from NIH funding changes is cascading through the research ecosystem," said Tanya Samazan, Editor-In-Chief. "Our survey shows just how deeply this uncertainty is affecting labs—from basic research to clinical trial infrastructure." Survey Highlights: Budget Cuts Across the Board Conducted by the Science Advisory Board (SAB) between mid- and late May, the survey collected 117 responses from U.S.-based labs, with 88 indicating their labs were impacted by NIH-related funding disruptions. Key findings include: 59% of labs report direct impacts from NIH-related grant or contract terminations, delays, or reductions. 47% report indirect impacts. Among affected labs, nearly 60% have reduced 2025 operating budgets by more than 10%. 51% report capital budget reductions exceeding 10%. When excluding labs that were uncertain or unaffected, the scale becomes even more dramatic: 71% of labs report operating budget cuts of over 10%. 71% report similar reductions in capital budgets. Lab Tools and Consumables Hit Hardest Every category of lab spending has been affected, according to survey data: 80% of labs have reduced their 2025 consumables budgets, making it the most impacted category. 63% have cut software/informatics budgets. 70% have reduced spending on devices under $50,000. Even high-end instrumentation (>$150,000) hasn't been spared, with 62% of labs trimming these budgets. Institutes Most Affected The survey findings align with NIH grant termination data indicating the hardest-hit institutions include: National Institute of Mental Health, with over $400 million in losses. National Institute of General Medical Sciences, which lost the highest number of grants (134). Institutes heavily reliant on lab instruments, including the National Institute of Biomedical Imaging and Bioengineering and the National Human Genome Research Institute. Medical schools and hospitals have borne a significant share of the burden, accounting for 50% of terminated grants and 55% of total terminated NIH dollars. A Shifting Landscape with No Clear Path Forward The rapidly evolving nature of NIH decisions—including ongoing terminations and reinstatements—has created a volatile funding environment. Labs are being forced to make difficult decisions with limited visibility into future funding. About Instrument Business Outlook (IBO)IBO is a leading newsletter providing market intelligence for the analytical instrument industry. Published by Strategic Directions International (SDi), a division of Science and Medicine Group, IBO offers in-depth coverage of technology, business, and market trends affecting the life sciences and lab tools sectors. View original content to download multimedia: SOURCE Instrument Business Outlook Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
43 minutes ago
- Yahoo
Shutterstock Receives Stockholder Approval for Proposed Merger with Getty Images
NEW YORK, June 10, 2025 /PRNewswire/ -- Shutterstock, Inc. (NYSE: SSTK) ("Shutterstock"), a leading global creative platform offering high-quality creative content for transformative brands, digital media and marketing companies, today announced that Shutterstock's stockholders approved the adoption of the merger agreement between Shutterstock and Getty Images Holdings, Inc. (NYSE: GETY) ("Getty Images"), with approximately 82% of the issued and outstanding shares of Shutterstock common stock voting in favor, at today's special meeting of Shutterstock stockholders. Stockholder approval marks an important milestone in the process of combining Shutterstock and Getty Images to create a premier visual content company. The combined company will be well-positioned to meet the ever-changing needs of customers through combined investment in content creation, event coverage, and product and technology innovation. "We are very pleased that our stockholders recognize the compelling rationale of this transaction and look forward to the successful completion of our merger with Getty Images," said Paul Hennessy, Shutterstock's Chief Executive Officer. "Our complementary strengths will allow us to better serve customers while also delivering exceptional value to our partners, contributors and stockholders in a fast evolving and competitive environment." Both parties continue to expect the transaction to close in the second half of 2025, subject to required regulatory approvals and other customary conditions. The final voting results will be reported on a Form 8-K filed with the Securities and Exchange Commission. ABOUT SHUTTERSTOCKShutterstock, Inc. (NYSE: SSTK) is a leading global creative platform offering high-quality creative content for transformative brands, digital media and marketing companies. Fueled by millions of creators around the world, a growing data engine and a dedication to product innovation, Shutterstock is the leading global platform for licensing from the most extensive and diverse collection of high-quality 3D models, videos, music, photographs, vectors and illustrations. From the world's largest content marketplace, to breaking news and A-list entertainment editorial access, to all-in-one content editing platform and studio production services—all using the latest in innovative technology—Shutterstock offers the most comprehensive selection of resources to bring storytelling to life. Learn more at and follow us on LinkedIn, Instagram, X, Facebook and YouTube. FORWARD-LOOKING STATEMENTSThe statements in this press release, and any related oral statements, include forward-looking statements concerning Getty Images, Shutterstock, the proposed transaction described herein and other matters. All statements, other than historical facts, are forward-looking statements. Forward-looking statements may discuss goals, intentions and expectations as to future plans, trends, events, results of operations or financial condition, financings or otherwise, based on current beliefs and involve numerous risks and uncertainties that could cause actual results to differ materially from expectations. Forward-looking statements speak only as of the date they are made or as of the dates indicated in the statements and should not be relied upon as predictions of future events, as there can be no assurance that the events or circumstances reflected in these statements will be achieved or will occur or the timing thereof. Forward-looking statements can often, but not always, be identified by the use of forward-looking terminology including "believes," "expects," "may," "will," "should," "could," "might," "seeks," "intends," "plans," "pro forma," "estimates," "anticipates," "designed," or the negative of these words and phrases, other variations of these words and phrases or comparable terminology, but not all forward-looking statements include such identifying words. Forward-looking statements are based upon current plans, estimates and expectations that are subject to risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary. The forward-looking statements in this press release relate to, among other things, obtaining applicable regulatory approvals for the proposed transaction on a timely basis or otherwise, satisfying other closing conditions to the proposed transaction, on a timely basis or otherwise, the expected tax treatment of the proposed transaction, the expected timing of the proposed transaction, and the integration of the businesses and the expected benefits, cost savings, accretion, synergies and growth to result therefrom. Important factors that could cause actual results to differ materially from the forward-looking statements include, among other things: failure to obtain applicable regulatory approvals in a timely manner or otherwise; interloper risk; failure to satisfy other closing conditions to the transaction or to complete the transaction on anticipated terms and timing (or at all); negative effects of the announcement of the transaction on the ability of Shutterstock or Getty Images to retain and hire key personnel and maintain relationships with customers, suppliers and others who Shutterstock or Getty Images does business, or on Shutterstock or Getty Images' operating results and business generally; risks that the businesses will not be integrated successfully or that the combined company will not realize expected benefits, cost savings, accretion, synergies and/or growth, as expected (or at all), or that such benefits may take longer to realize or may be more costly to achieve than expected; the risk that disruptions from the transaction will harm business plans and operations; risks relating to unanticipated costs of integration; significant transaction and/or integration costs, or difficulties in connection with the transaction and/or unknown or inestimable liabilities; restrictions during the pendency of the transaction that may impact the ability to pursue certain business opportunities or strategic transactions; potential litigation associated with the transaction; the potential impact of the announcement or consummation of the transaction on Getty Images', Shutterstock's or the combined company's relationships with suppliers, customers, employers and regulators; demand for the combined company's products; potential changes in the Getty Images stock price that could negatively impact the value of the consideration offered to the Shutterstock stockholders; the occurrence of any event that could give rise to the termination of the proposed transaction; and Getty Images' ability to complete any refinancing of its debt or new debt financing on a timely basis, on favorable terms or at all. A more fulsome discussion of the risks related to the proposed transaction is included in the information statement and proxy statement/prospectus filed with the SEC by Shutterstock and Getty Images in connection with the proposed transaction. For a discussion of factors that could cause actual results to differ materially from those contemplated by forward-looking statements, see the section captioned "Risk Factors" in each of Getty Images' and Shutterstock's Annual Report on Form 10-K for the fiscal year ended December 31, 2024, subsequent Quarterly Reports on Form 10-Q and other filings with the SEC. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward looking statements. While the list of factors presented here is, and the list of factors presented in the information statement and proxy statement/prospectus filed with the SEC by Shutterstock and Getty Images in connection with the proposed transaction is considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward looking statements. Neither Getty Images nor Shutterstock assumes, and each hereby disclaims, any obligation to update forward-looking statements, except as may be required by law. View original content to download multimedia: SOURCE Shutterstock, Inc. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
